Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Director, Biologics-Antibody Engineering, Pharmaceutical Development at Santen, Inc.
Dr. Guna Kannan has more than 15 years of experience in protein engineering and developing innovative technologies such as the multi-specific antibodies. He currently holds Director position at Santen and leads design and development of New Biologics Entity. Prior to joining Santen, he was Director of Antibody Engineering and CMC at Affinita Biotech and Principal Scientist and Protein Engineering and Optimization group's head at Amgen. Guna has co-authored 60+ peer-reviewed research articles and patents on clinical molecules and novel technologies.